Rapid hemostasis at the femoral venous access site using a novel hemostatic pad containing kaolin after atrial fibrillation ablation

Journal of Interventional Cardiac Electrophysiology

Volumn 31, Issue 2, 2011, Pages 157-164

  Sairaku, Akinori ^a   Nakano, Yukiko ^a   Oda, Noboru ^a   Makita, Yuko ^a   Kajihara, Kenta ^a   Tokuyama, Takehito ^a   Kihara, Yasuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

AF ablation; Hemostatic pad; Kaolin; Quick Clot; Rebleeding; Venous access site

Indexed keywords

KAOLIN;

ABLATION THERAPY; ADULT; ARTICLE; BLOOD CLOTTING TIME; CLINICAL EFFECTIVENESS; CLIP; COMPRESSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FEMORAL VEIN; HEART ATRIUM FIBRILLATION; HEMATOMA; HEMOSTASIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SHEATH REMOVAL;

AGED; ATRIAL FIBRILLATION; CATHETERS, INDWELLING; COMPRESSION BANDAGES; FEMALE; FEMORAL VEIN; FOLLOW-UP STUDIES; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; KAOLIN; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REFERENCE VALUES; RISK ASSESSMENT; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 80053565516     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-011-9552-6     Document Type: Article

References (41)

1. Kannel, W. B., Abbott, R. D., Savage, D. D., & McNamara, P. M. (1982). Epidemiologic features of chronic atrial fibrillation: the Framingham study. The New England Journal of Medicine, 306, 1018-1022 (Pubitemid 12155370)
2. Haïssaguerre, M., Jaïs, P., Shah, D. C., Takahashi, A., Hocini, M., Quiniou, G., et al. (1998). Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. The New England Journal of Medicine, 339, 659-666 (Pubitemid 28402090)
3. Pappone, C., Rosanio, S., Oreto, G., Tocchi, M., Gugliotta, F., Vicedomini, G., et al. (2000). Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation, 102, 2619-2628
4. Wyse, D. G., Waldo, A. L., DiMarco, J. P., Domanski, M. J., Rosenberg, Y., Schron, E. B., et al. (2002). A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England Journal of Medicine, 347, 1825-1833 (Pubitemid 35417773)
5. Ouyang, F., Bänsch, D., Ernst, S., Schaumann, A., Hachiya, H., Chen, M., et al. (2004). Complete isolation of left atrium surrounding the pulmonary veins: new insights from the double- Lasso technique in paroxysmal atrial fibrillation. Circulation, 110, 2090-2096 (Pubitemid 39372484)
6. Cappato, R., Calkins, H., Chen, S. A., Davies, W., Iesaka, Y., Kalman, J., et al. (2005). Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation, 111, 1100-1105 (Pubitemid 40365469)
7. Bertaglia, E., Zoppo, F., Tondo, C., Colella, A., Mantovan, R., Senatore, G., et al. (2007). Early complications of pulmonary vein catheter ablation for atrial fibrillation: a multicenter prospective registry on procedural safety. Heart Rhythm, 4, 1265-1271 (Pubitemid 47495727)
8. Dagres, N., Hindricks, G., Kottkamp, H., Sommer, P., Gaspar, T., Bode, K., et al. (2009). Complications of atrial fibrillation ablation in a high-volume center in 1, 000 procedures: still cause for concern? Journal of Cardiovascular Electrophysiology, 20, 1014-1019
9. Ellis, E. R., Culler, S. D., Simon, A. W., & Reynolds, M. R. (2009). Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm, 6, 1267-1273
10. Kapadia, S. R., Raymond, R., Knopf, W., Jenkins, S., Chapekis, A., Ansel, G., et al. (2001). The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry. The American Journal of Cardiology, 87, 789-791 (Pubitemid 32209102)
11. Bhatt, D. L., Raymond, R. E., Feldman, T., Braden, G. A., Murphy, B., Strumpf, R., et al. (2002). Successful "pre-closure" of 7Fr and 8Fr femoral arteriotomies with a 6Fr suture-based device (the Multicenter Interventional Closer Registry). The American Journal of Cardiology, 89, 777-779 (Pubitemid 34230581)
12. Applegate, R. J., Grabarczyk, M. A., Little, W. C., Craven, T., Walkup, M., Kahl, F. R., et al. (2002). Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. Journal of the American College of Cardiology, 40, 78-83 (Pubitemid 34701380)
13. Jaff, M. R., Hadley, G., Hermiller, J. B., Simonton, C., Hinohara, T., Cannon, L., et al. (2006). The safety and efficacy of the StarClose Vascular Closure System: the ultrasound substudy of the CLIP study. Catheterization and Cardiovascular Interventions, 68, 684-689 (Pubitemid 44721087)
14. Bangalore, S., Arora, N., & Resnic, F. S. (2009). Vascular closure device failure: frequency and implications: a propensity-matched analysis. Circulation. Cardiovascular Interventions, 2, 549-556
15. Coto, H. A. (2002). Closure of the femoral vein puncture site after transcatheter procedures using Angio-Seal. Catheterization and Cardiovascular Interventions, 55, 16-19 (Pubitemid 34008077)
16. Mahadevan, V. S., Jimeno, S., Benson, L. N., McLaughlin, P. R., & Horlick, E. M. (2008). Pre-closure of femoral venous access sites used for large-sized sheath insertion with the Perclose device in adults undergoing cardiac intervention. Heart, 94, 571-572 (Pubitemid 351580127)
17. Kinnaird, T. D., Stabile, E., Mintz, G. S., Lee, C. W., Canos, D. A., Gevorkian, N., et al. (2003). Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. The American Journal of Cardiology, 92, 930-935 (Pubitemid 37214804)
18. Pristipino, C., Pelliccia, F., Granatelli, A., Pasceri, V., Roncella, A., Speciale, G., et al. (2007). Comparison of access-related bleeding complications in women versus men undergoing percutaneous coronary catheterization using the radial versus femoral artery. The American Journal of Cardiology, 99, 1216-1221 (Pubitemid 46659861)
19. Bertrand, O. F., Larose, E., Rodés-Cabau, J., Gleeton, O., Taillon, I., Roy, L., et al. (2009). Incidence, predictors, and clinical impact of bleeding after transradial coronary stenting and maximal antiplatelet therapy. American Heart Journal, 157, 164-169
20. Cox, N., Resnic, F. S., Popma, J. J., Simon, D. I., Eisenhauer, A. C., & Rogers, C. (2004). Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. The American Journal of Cardiology, 94, 1174-1177 (Pubitemid 39424224)
21. Byrne, J., Spence, M. S., Fretz, E., Mildenberger, R., Chase, A., Berry, B., et al. (2009). Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry). The American Journal of Cardiology, 103, 507-511
22. Chew, D. P., Bhatt, D. L., Lincoff, A. M., Moliterno, D. J., Brener, S. J., Wolski, K. E., et al. (2001). Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials. Circulation, 103, 961-966 (Pubitemid 32183801)
23. Hillegass, W. B., Brott, B. C., Chapman, G. D., Phillips, H. R., Stack, R. S., Tcheng, J. E., et al. (2002). Relationship between activated clotting time during percutaneous intervention and subsequent bleeding complications. American Heart Journal, 144, 501-507
24. Brener, S. J., Moliterno, D. J., Lincoff, A. M., Steinhubl, S. R., Wolski, K. E., & Topol, E. J. (2004). Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. Circulation, 110, 994-998 (Pubitemid 39128625)
25. Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., & Roth, D. (1999). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Annals of Internal Medicine, 130, 461-470 (Pubitemid 29135798)
26. Margolis, J. (1958). The kaolin clotting time; a rapid one-stage method for diagnosis of coagulation defects. Journal of Clinical Pathology, 11, 406-409
27. Sugo, T., Kato, H., Iwanaga, S., Takada, K., & Sakakibara, S. (1985). Kinetic studies on surface-mediated activation of bovine factor XII and prekallikrein. Effects of kaolin and high-Mr kininogen on the activation reactions. European Journal of Biochemistry, 146, 43-50 (Pubitemid 15188163)
28. Politi, L., Aprile, A., Paganelli, C., Amato, A., Zoccai, G.B., Sgura, F., et al. (2010). Randomized clinical trial on short-time compression with kaolin-filled pad: a new strategy to avoid early bleeding and subacute radial artery occlusion after percutaneous coronary intervention. Journal of Interventional Cardiology, Aug29. [Epub ahead of print]
29. Sena, M. J., Larson, S., Piovesan, N., & Vercruysse, G. (2010). Surgical application of kaolin-impregnated gauze (Combat Gauze) in severe hemorrhagic gastritis. The American Surgeon, 76, 774-775.
30. Nguyen, N., Hasan, S., Caufield, L., Ling, F. S., & Narins, C. R. (2007). Randomized controlled trial of topical hemostasis pad use for achieving vascular hemostasis following percutaneous coronary intervention. Catheterization and Cardiovascular Interventions, 69, 801-807 (Pubitemid 46867480)
31. Balzer, J. O., Schwarz, W., Thalhammer, A., Eichler, K., Schmitz- Rixen, T., & Vogl, T. J. (2007). Postinterventional percutaneous closure of femoral artery access sites using the Clo-Sur PAD device: initial findings. European Radiology, 17, 693-700
32. Mlekusch, W., Minar, E., Dick, P., Sabeti, S., Bartok, A., Haumer, M., et al. (2008). Access site management after peripheral percutaneous transluminal procedures: Neptune pad compared with conventional manual compression. Radiology, 249, 1058-1063
33. Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., et al. (1996). Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet, 348, 423-428 (Pubitemid 26267872)
34. Patel, A. A., Clyne, C. A., Henyan, N. N., White, C. M., Zembrowski, B. F., Migeed, M., et al. (2007). The use of protamine after radiofrequency catheter ablation: a pilot study. Journal of Interventional Cardiac Electrophysiology, 18, 155-158 (Pubitemid 46835765)
35. Gianakos, S., Keeling, A. W., Haines, D., & Haugh, K. (2004). Time in bed after electrophysiological procedures (TIBS IV): a pilot study. American Journal of Critical Care, 13(56-58),87.
36. Strandness, D. E., & Summer, D. S. (1975). Hemodynamics for Surgeons (pp. 120-157). New York: Grune & Stratton Inc
37. Wazni, O. M., Beheiry, S., Fahmy, T., Barrett, C., Hao, S., Patel, D., et al. (2007). Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation, 116, 2531-2534 (Pubitemid 350179218)
38. Hussein, A. A., Martin, D. O., Saliba, W., Patel, D., Karim, S., Batal, O., et al. (2009). Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: a safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm, 6, 1425-1429
39. Schmidt, M., Segerson, N. M., Marschang, H., Akoum, N., Rittger, H., Clifford, S. M., et al. (2009). Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing and Clinical Electrophysiology, 32, 995-999
40. Calkins, H., Brugada, J., Packer, D. L., Cappato, R., Chen, S. A., Crijns, H. J., et al. (2007). HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm, 4, 816-861 (Pubitemid 46850611)
41. Meyerovitz, M. F. (1990). How to maximize the safety of coronary and pulmonary angiography in patients receiving thrombolytic therapy. Chest, 97, 132S-135S. (Pubitemid 20119564)